| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/03/2003 | US20030124547 Determining copy number in genome based on dosage/diploid signals; single nucleotide polymorphisms; oligonucleotides |
| 07/03/2003 | US20030124546 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex |
| 07/03/2003 | US20030124545 Quantitative assay for the simultaneous detection and speciation of bacterial infections |
| 07/03/2003 | US20030124544 Method for testing nucleic acid sequence |
| 07/03/2003 | US20030124543 Tumor diagnosis; anticarcinogenic agents; animal models |
| 07/03/2003 | US20030124542 Microarray for detecting chromatin aberrations; anticarcinogenic agents; antitumor agents; tissue engineering |
| 07/03/2003 | US20030124540 Interventions to mimic the effects of calorie restriction |
| 07/03/2003 | US20030124538 Reverse two-hybrid systems |
| 07/03/2003 | US20030124536 Identifying alleles of polymorphic regions of a phospholipase c or plasminogen activator inhibitor gene; use for determining susceptibility |
| 07/03/2003 | US20030124535 Identifying alleles of polymorphic regions of a lysyl hydroxylase gene; use for determining susceptibility |
| 07/03/2003 | US20030124534 Measuring expression of nucleotide sequences in cells |
| 07/03/2003 | US20030124532 Binding with ligands covalently tethered to a substrate surface; separation and detection; heme, siderophore, polysaccharide or peptide |
| 07/03/2003 | US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124530 Sequence-directed DNA-binding molecules compositons and methods |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124528 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 07/03/2003 | US20030124525 Solid supports (e.g., glass) and polymer hydrogels (particularly polymer hydrogel arrays present on a solid support) comprising one or more reactive sites for the attachment of biomolecules, as well as biomolecules |
| 07/03/2003 | US20030124524 Screening assays for identifying modulators of the inflammatory or immune response |
| 07/03/2003 | US20030124523 Organic compounds |
| 07/03/2003 | US20030124522 Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips |
| 07/03/2003 | US20030124521 Peptide nucleic acids; use in detection and analysis of point mutations |
| 07/03/2003 | US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 07/03/2003 | US20030124519 Cell specific anti-viral drug susceptibility test using tagged permissive target cells |
| 07/03/2003 | US20030124518 Immunoassay for HIV protease inhibitors |
| 07/03/2003 | US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 07/03/2003 | US20030124515 Target amplification of nucleic acid with mutant RNA polymerase |
| 07/03/2003 | US20030124514 Methods of assessing HIV integrase inhibitor therapy |
| 07/03/2003 | US20030124512 Simultaneous quantification of nucleic acids in diseased cells |
| 07/03/2003 | US20030124510 Protein whose genome contains a region which is homologous to DNA restriction enzyme present in plasmid of escherichia coli; immunologically reactive; use in diagnostics and vaccines |
| 07/03/2003 | US20030124508 Method for testing the hormonal effect of substances |
| 07/03/2003 | US20030124507 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
| 07/03/2003 | US20030124505 Recombinase; polynucleotide which hybridizes to target nucleic acid; robotic system to manipulate pipettors, sample/plate handlers and other devices |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124133 Polypeptide having a first domain with carbohydrate binding activity and a second domain with kinase activity; tumor immunotherapy |
| 07/03/2003 | US20030124128 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124108 Useful in wound healing, autoimmune disorders and inflammatory diseases |
| 07/03/2003 | US20030124107 PAK5-related compositions and methods |
| 07/03/2003 | US20030124096 DNA virus, which replicates via an RNA intermediate,that comprises a nucleotide mutation in a gene encoding a DNA polymerase or part thereof; particularly hepatitis B variants |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124029 Microtitre well plate; efficient binding analysis |
| 07/03/2003 | US20030123057 Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions |
| 07/03/2003 | US20030121753 Method and apparatus for document processing |
| 07/03/2003 | US20030121752 Method and apparatus for document processing |
| 07/03/2003 | DE19964220C2 Modified nucleic acid oligomer, useful for sequencing by hybridization, is substituted by redox agent to allow electrical detection of hybridization |
| 07/03/2003 | CA2643133A1 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 07/03/2003 | CA2495021A1 System and methods for measuring at least one metabolic rate of a plurality of cells |
| 07/03/2003 | CA2471417A1 Uses of an endothelial cell receptor |
| 07/03/2003 | CA2471376A1 Nucleotide polymorphisms associated with osteoporosis |
| 07/03/2003 | CA2471371A1 Methods for identifying gibberellin responsive genes using cultured plant cells |
| 07/03/2003 | CA2471369A1 Glycosyl hydrolases obtained from metagenomic analysis |
| 07/03/2003 | CA2471198A1 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof |
| 07/03/2003 | CA2471145A1 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/03/2003 | CA2471116A1 Method for cloning of variable domain sequences |
| 07/03/2003 | CA2470950A1 Normalisation of microarray data based on hybridisation with an internal reference |
| 07/03/2003 | CA2470943A1 Forming and modifying dielctrically-engineered microparticles |
| 07/03/2003 | CA2470844A1 Novel compositions and methods for cancer |
| 07/03/2003 | CA2470724A1 Devices and methods for isolating and detecting specific substances in complex matrices |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470325A1 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease |
| 07/03/2003 | CA2470287A1 Tripartite molecular beacons |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2470088A1 Identification of an amplified gene and target for drug intervention |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469980A1 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 07/03/2003 | CA2469972A1 Bone polypeptide-1 |
| 07/03/2003 | CA2469928A1 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 07/03/2003 | CA2469375A1 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 07/03/2003 | CA2469263A1 Raf/ras binding compounds |
| 07/03/2003 | CA2468972A1 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 07/03/2003 | CA2468882A1 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | CA2468778A1 Isolation tool for viable c-kit expressing cells |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2466885A1 Non-human primate fc receptors and methods of use |
| 07/03/2003 | CA2466483A1 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/03/2003 | CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | CA2464885A1 A method of reducing non-specific amplification in pcr |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2462587A1 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | CA2451677A1 Compositions and methods utilizing dna polymerases |
| 07/02/2003 | EP1324357A1 Electromagnetic device and high-voltage generating device and method of producing electromagnetic device |
| 07/02/2003 | EP1324352A2 Organic conductor |
| 07/02/2003 | EP1324045A2 Factorial chemical libraries |
| 07/02/2003 | EP1324043A1 Solid supports having surface-treated layer formed thereon |
| 07/02/2003 | EP1324042A2 Detection and/or quantication method of a target molecule by a binding with a capture molecule fixed on the surface of a disc |
| 07/02/2003 | EP1324040A2 Direct selection of cells by secretion product |
| 07/02/2003 | EP1324038A2 Method for producing reagent coated test strip |
| 07/02/2003 | EP1323835A2 Method for determining biospecies contained in test specimen and kit used for the same |
| 07/02/2003 | EP1323834A2 Target detection method, reagent and method for detecting SNP of DNA nucleotide sequences |
| 07/02/2003 | EP1323833A1 Method of determining base sequence |
| 07/02/2003 | EP1323832A1 Culture medium and method for identifying gram-negative microorganisms |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323728A2 Method of preparing a standard diagnostic gene transcript pattern |
| 07/02/2003 | EP1323427A1 Method for diagnosing and treating dentinogenesis imperfecta type ii by using dentin sialophosphoprotein (dspp) gene and its encoding product |
| 07/02/2003 | EP1322958A2 Selective binding materials |
| 07/02/2003 | EP1322957A2 Diagnostic markers of acute coronary syndromes and methods of use thereof |